|
|
| | MAB-CHMINACA-d4 Basic information |
| Product Name: | MAB-CHMINACA-d4 | | Synonyms: | (+/-)-adb-chminaca;N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-4,5,6,7-tetradeuterioindazole-3-carboxamide;(+)-Veraguensin | | CAS: | 2747913-91-1 | | MF: | C21H26D4N4O2 | | MW: | 374.51 | | EINECS: | | | Product Categories: | | | Mol File: | 2747913-91-1.mol |  |
| | MAB-CHMINACA-d4 Chemical Properties |
| Boiling point | 626.144±35.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.238±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) |
| | MAB-CHMINACA-d4 Usage And Synthesis |
| Description | MAB-CHMINACA-d4 (CRM) is intended for use as an internal standard for the quantification of MAB-CHMINACA by GC- or LC-MS. MAB-CHMINACA is a potent agonist of the CB1 receptor with a reported Ki value of 0.289 nM.1 This product is intended for forensic and research applications. | | References | 1. Buchler, I.P., Hayes, M.J., Hedge, S.G., et al. Indazole derivatives ,1-283(2009). |
| | MAB-CHMINACA-d4 Preparation Products And Raw materials |
|